Digital Look

Human Genome Sciences Inc. (HGSI)

$ 13.61

By Michael Millar

Date: Wednesday 09 May 2012

GlaxoSmithKline has taken an offer of 13 dollars a share directly to the shareholders of Human Genome Sciences (HGS).

US close: Stocks down second day running	19-Apr-2012	ShareCast
Glaxo sees offer rejected by Human Genome Sciences	19-Apr-2012	ShareCast
US pre-open: Morgan Stanley and Bank of America ...	19-Apr-2012	ShareCast
US broker round-up	19-Jan-2012	ShareCast

Lupus Drug Shows Promise in New Trial	03-Nov-2009	New York Times
HGS Stock Up 277% On Lupus Results	21-Jul-2009	Washington Post
Local Briefing	11-Mar-2009	Washington Post
Local Briefing	27-Feb-2009	Washington Post
Local Briefing	18-Feb-2009	Washington Post

Searching for a Cure-All	24-Mar-2009	Washington Post
A Biotech Firm's New Formula	31-Jul-2006	Washington Post
Stock Futures Up After Losses Last Session	06-Jun-2006	Chicago Tribune
AstraZeneca buying rest of biotech company	15-May-2006	Intl Herald Tribune
Will Human Genome Sciences finally be able to ma...	02-Jan-2006	Washington Post

Morning Stock Focus List for Tuesday, June 06, 2...	06-Jun-2006	Market Wire
Stock Watch: Emerging Public Company Continues C...	15-Mar-2006	Market Wire
Human Genome Sciences Invites Investors to Liste...	10-Mar-2006	PR Newswire
Human Genome Sciences Reports Financial Results ...	09-Feb-2006	PR Newswire

Human Genome Sciences Announces Closing of Publi...	03-Aug-2009	PR Newswire
Human Genome Sciences Announces Pricing of Publi...	28-Jul-2009	PR Newswire
Human Genome Sciences Announces Proposed Public ...	27-Jul-2009	PR Newswire
Human Genome Sciences Announces Second-Quarter 2...	22-Jul-2009	PR Newswire
Human Genome Sciences Announces New Order for Ra...	22-Jul-2009	PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.